ASMTL and hepatocellular carcinoma: To further make sure the role of ASMTL‐AS1/miR‐342‐3p/NLK/YAP axis in residual HCC after insufficient RFA, we analysed the expression of relevant genes in the serum and serum exosomes (SEs) from HCC patients including those with insufficient RFA.